Unlock AI-driven, actionable R&D insights for your next breakthrough.

Crosslinked Polyethylene Glycol Hydrogel: Advanced Synthesis Strategies, Structural Optimization, And Biomedical Applications

MAR 25, 202655 MINS READ

Want An AI Powered Material Expert?
Here's PatSnap Eureka Materials!
Crosslinked polyethylene glycol hydrogel represents a pivotal class of biomaterials characterized by three-dimensional network structures formed through covalent or physical crosslinking of polyethylene glycol (PEG) chains in aqueous environments. These hydrogels exhibit exceptional biocompatibility, tunable mechanical properties, controlled degradation kinetics, and versatile functionalization capabilities, making them indispensable platforms for drug delivery systems, tissue engineering scaffolds, surgical sealants, and regenerative medicine applications 123. The strategic design of crosslinking chemistries—ranging from Michael-type addition reactions and Schiff base formation to photopolymerization and enzymatic coupling—enables precise control over gelation kinetics, network architecture, and biological responsiveness 456.
Want to know more material grades? Try PatSnap Eureka Material.

Molecular Architecture And Crosslinking Mechanisms Of Polyethylene Glycol Hydrogel Networks

The fundamental structure of crosslinked polyethylene glycol hydrogel comprises hydrophilic PEG chains interconnected through covalent bonds or reversible physical interactions to form three-dimensional networks capable of absorbing substantial quantities of water while maintaining structural integrity 12. The molecular weight of PEG precursors critically influences network properties: lower molecular weight PEG (1,000–10,000 Da) yields denser networks with higher mechanical strength but reduced swelling capacity, whereas higher molecular weight variants (10,000–30,000 Da) produce more elastic, highly swollen hydrogels suitable for soft tissue applications 1018.

Chemical Crosslinking Strategies For Polyethylene Glycol Hydrogel Formation

Nucleophile-Electrophile Coupling Reactions: The most widely employed strategy involves mixing multi-arm PEG derivatives functionalized with nucleophilic groups (primary amines, thiols) and electrophilic counterparts (succinimidyl esters, acrylates, vinyl sulfones) 2811. For instance, four-arm PEG-amine (10 kDa) reacts with four-arm PEG-succinimidyl glutarate via amide bond formation, achieving gelation within 10–60 seconds depending on concentration (5–20 wt%) and pH (7.4–8.5) 45. The resulting hydrogels exhibit compressive moduli ranging from 1–50 kPa and degradation half-lives of 7–180 days through ester hydrolysis 25.

Michael-Type Addition Reactions: Thiol-functionalized PEG crosslinkers (e.g., dithiol-PEG with molecular weight 1,000–20,000 Da) react with acrylate- or vinyl sulfone-terminated PEG under physiological conditions (pH 7–8, 25–37°C) without catalysts, forming stable thioether linkages 3618. A representative formulation combines 8-arm PEG-acrylate (20 kDa, 10 wt%) with linear dithiol-PEG (3.4 kDa, molar ratio 1:1.2 thiol:acrylate), yielding hydrogels with tensile strength 15–30 kPa, elongation at break 200–400%, and gelation time <5 minutes 612. This chemistry avoids cytotoxic byproducts and enables in situ gelation for minimally invasive delivery 3.

Schiff Base Formation With O-Phthalaldehyde: Recent innovations employ PEG derivatives bearing o-phthalaldehyde terminal groups that rapidly condense with amino-containing crosslinkers (e.g., PEG-diamine, lysine-rich peptides) to form imine bonds 113. A dual-component system comprising 4-arm PEG-o-phthalaldehyde (10 kDa, 15 wt%) and 4-arm PEG-amine (10 kDa, 15 wt%) achieves gelation within 3–10 seconds at pH 7.4, producing hydrogels with adhesive strength to wet tissue surfaces exceeding 20 kPa and swelling ratios <50% 113. The rapid kinetics and low swelling address limitations of conventional PEG hydrogels in surgical sealing applications 13.

Photopolymerization And Radical Crosslinking: PEG macromers functionalized with acrylate or methacrylate end groups undergo free radical polymerization upon UV irradiation (365 nm, 5–10 mW/cm², 1–5 minutes) in the presence of photoinitiators (e.g., Irgacure 2959, 0.05–0.1 wt%) 69. A typical formulation uses PEG-diacrylate (6 kDa, 20 wt%) to form hydrogels with compressive modulus 50–200 kPa and mesh size 5–15 nm, suitable for encapsulating cells or proteins 916. However, residual photoinitiator and radical species may compromise biocompatibility, necessitating thorough washing or alternative visible-light systems 9.

Physical Crosslinking And Hybrid Network Designs

Temperature-Responsive Gelation: Thermosensitive PEG-based copolymers, such as polyphosphazene grafted with methoxy-PEG and amino acid esters, exhibit sol-gel transitions at physiological temperatures (32–37°C) 67. These systems remain liquid at room temperature for easy mixing with therapeutics, then gel upon injection into the body without chemical crosslinkers 7. However, purely physical gels often lack mechanical robustness; hybrid designs combining chemical crosslinks (e.g., Michael addition) with thermosensitive domains achieve both injectability and enhanced strength (storage modulus 1–10 kPa) 612.

Dual-Network And Interpenetrating Polymer Networks: Incorporating secondary polymers (hyaluronic acid, dextran, alginate) into PEG networks via sequential crosslinking or interpenetration enhances mechanical properties and biological functionality 91216. For example, a dual-network hydrogel comprising chemically crosslinked PEG-diacrylate (first network) and ionically crosslinked alginate (second network via Ca²⁺) exhibits compressive strength >100 kPa and toughness 500–1000 J/m², mimicking cartilage tissue 12. Electron beam irradiation (10–50 kGy) can induce crosslinking in PEG/hyaluronic acid blends without chemical additives, yielding biocompatible hydrogels with tunable degradation (3–40 days) 9.

Physicochemical Properties And Structure-Property Relationships In Crosslinked Polyethylene Glycol Hydrogel

Swelling Behavior And Water Retention Capacity

Swelling ratio—defined as (mass_swollen - mass_dry)/mass_dry—is a critical parameter governing drug diffusion, mechanical compliance, and tissue integration 2513. Conventional PEG hydrogels exhibit swelling ratios of 200–600%, which can cause tissue compression and reduced adhesion in vivo 213. Swelling is inversely proportional to crosslink density: increasing PEG-acrylate concentration from 10 to 30 wt% reduces equilibrium swelling from 500% to 150% while raising compressive modulus from 5 to 80 kPa 210. Incorporating hydrophobic segments (polylactide, polycaprolactone blocks) or using polysaccharide-based crosslinkers (e.g., o-phthalaldehyde-modified dextran) can limit swelling to <50%, enhancing dimensional stability for surgical sealants 113.

Mechanical Properties And Elasticity

Compressive And Tensile Moduli: Crosslinked PEG hydrogels typically exhibit compressive moduli of 1–200 kPa depending on polymer concentration, molecular weight, and crosslink density 256. A representative formulation of 4-arm PEG-succinimidyl glutarate (10 kDa, 15 wt%) crosslinked with trilysine yields compressive modulus ~10 kPa and tensile strength ~5 kPa, suitable for soft tissue adhesion 58. Higher crosslink densities (achieved via 8-arm PEG or increased macromer concentration) elevate modulus to 50–200 kPa but reduce elongation at break from 400% to <100%, compromising flexibility 610.

Viscoelastic Behavior: Dynamic mechanical analysis reveals storage modulus (G') typically 2–10 times greater than loss modulus (G'') across physiological frequencies (0.1–10 Hz), indicating predominantly elastic behavior 612. Tan δ (G''/G') values of 0.1–0.3 confirm solid-like characteristics essential for load-bearing applications 12. Temperature sweeps show minimal modulus change from 25–40°C for chemically crosslinked networks, contrasting with thermosensitive physical gels that exhibit sharp modulus increases above lower critical solution temperature 67.

Degradation Kinetics And Bioabsorption Profiles

Hydrolytic Degradation Mechanisms: Ester linkages within PEG-based networks (e.g., succinimidyl glutarate, lactide/glycolide segments) undergo hydrolysis at rates dependent on pH, temperature, and local enzyme activity 2517. A PEG hydrogel incorporating poly(lactic-co-glycolic acid) (PLGA) segments (lactide:glycolide 50:50, segment length 2–5 repeat units) exhibits mass loss initiating at 3–7 days and complete degradation within 30–60 days at 37°C, pH 7.4 217. Degradation products—primarily low molecular weight PEG (<10 kDa) and lactic/glycolic acid—are renally cleared or metabolized, minimizing toxicity 29.

Enzymatic Degradation: Incorporating peptide sequences susceptible to matrix metalloproteinases (MMPs) enables cell-mediated remodeling 16. A PEG hydrogel crosslinked via MMP-cleavable peptides (e.g., GPQG↓IWGQ) degrades in response to cellular proteases, with half-life tunable from 5–30 days by varying peptide sequence and concentration 16. This approach supports tissue ingrowth and scaffold replacement in regenerative applications 16.

Synthesis Protocols And Process Optimization For Crosslinked Polyethylene Glycol Hydrogel Production

Precursor Synthesis And Functionalization

Activation Of PEG Hydroxyl Termini: Linear or multi-arm PEG (molecular weight 2,000–40,000 Da) is functionalized by reacting terminal hydroxyl groups with activating agents under anhydrous conditions 124. For succinimidyl ester functionalization, PEG is dissolved in anhydrous dichloromethane (DCM, 10 wt%), treated with disuccinimidyl glutarate (2–4 molar excess per hydroxyl) and triethylamine (3 molar excess) at 25°C for 12–24 hours under nitrogen 48. The product is precipitated in cold diethyl ether, filtered, and dried under vacuum (yield 85–95%, degree of substitution >95% by ¹H NMR) 4.

Thiol Functionalization Via Tosylation: PEG-diol is first tosylated using p-toluenesulfonyl chloride (1.5 equiv per OH) in pyridine at 0°C for 24 hours, then reacted with thiourea (5 equiv) in DMF at 80°C for 48 hours, followed by hydrolysis with NaOH (2 M) to yield PEG-dithiol 318. Purification by dialysis (MWCO 1,000 Da) against acidified water (pH 3–4) and lyophilization affords white powder with thiol content 1.8–2.0 mmol/g (theoretical 2.0 mmol/g for 1 kDa PEG-dithiol) 18.

O-Phthalaldehyde Conjugation: PEG-amine (4-arm, 10 kDa) is reacted with o-phthalaldehyde (1.2 equiv per amine) in phosphate buffer (pH 8.0, 50 mM) at 25°C for 2 hours 1. The conjugate is purified by ultrafiltration (MWCO 3,000 Da) and lyophilized, yielding yellow powder with aldehyde content confirmed by reaction with 2,4-dinitrophenylhydrazine (DNPH assay, >90% functionalization) 1.

Hydrogel Formation Procedures And Gelation Control

Dual-Syringe Mixing For In Situ Gelation: Precursor solutions (e.g., 4-arm PEG-NHS, 15 wt% in PBS; trilysine, 10 wt% in PBS) are loaded into separate syringes connected via a static mixer or Y-connector 5811. Upon simultaneous injection, mixing occurs within 0.5–2 seconds, and gelation completes in 5–60 seconds depending on reactivity and concentration 511. This method is standard for surgical sealants and adhesives, enabling precise delivery to irregular tissue surfaces 38.

Photopolymerization Protocols: PEG-diacrylate solution (10–30 wt% in PBS or culture medium) containing photoinitiator (Irgacure 2959, 0.05 wt%) is pipetted into molds or applied to substrates, then exposed to UV light (365 nm, 5–10 mW/cm²) for 1–5 minutes 916. Gelation is monitored by rheology (crossover of G' and G'') or visual inspection; complete crosslinking requires UV dose 300–3000 mJ/cm² 9. For cell encapsulation, cytocompatible photoinitiators (e.g., lithium phenyl-2,4,6-trimethylbenzoylphosphinate, LAP) and reduced UV intensity (<5 mW/cm²) are employed to maintain >90% cell viability 16.

Electron Beam Irradiation: Aqueous blends of PEG (10–30 wt%) and hyaluronic acid (1–5 wt%) are sealed in vials, degassed, and irradiated with electron beam (10–50 kGy dose, 10 MeV energy) at ambient temperature 9. Crosslinking proceeds via radical formation on polymer backbones without chemical additives; gelation occurs at doses >15 kGy, with optimal mechanical properties (compressive modulus 10–50 kPa) achieved at 25–35 kGy 9. This method avoids organic solvents and toxic crosslinkers, yielding sterile, biocompatible hydrogels 9.

Critical Process Parameters And Quality Control

pH And Buffer Selection: Nucleophile-electrophile reactions are pH-sensitive; amine-NHS coupling proceeds optimally at pH 7.5–8.5 where amines are deprotonated, while thiol-acrylate Michael addition tolerates pH 7.0–9.0 468. Phosphate-buffered saline (PBS, 10–50 mM, pH 7.4) is standard, but carbonate buffers (pH 9.0) accelerate gelation for rapid-setting applications 8.

Temperature Control: Most chemical crosslinking reactions are performed at 20–37°C; lower temperatures (4–15°C) slow gelation, extending working time for complex surgical procedures, while elevated temperatures (37–40°C) accelerate kinetics 56. Thermosensitive systems require strict temperature control during storage (<10°C) and application (>32°C) 7.

Stoichiometry And Functional Group Ratios: Optimal mechanical properties and complete network formation require near-stoichiometric ratios of reactive groups (e.g., amine:NHS 1:1, thiol:acrylate 1:1) 4612. Excess of one component (10–20%) can compensate for incomplete functionalization or side reactions but may leave unreacted species that leach out, affecting biocompatibility 412.

Applications Of Crosslinked Poly

OrgApplication ScenariosProduct/ProjectTechnical Outcomes
Changchun Institute of Applied Chemistry Chinese Academy of SciencesSurgical sealants, tissue adhesives, drug sustained-release carriers, and tissue engineering scaffolds requiring rapid setting and strong adhesion to wet biological tissues.O-Phthalaldehyde-Terminated PEG Hydrogel SystemRapid gelation within 3-10 seconds at pH 7.4, adhesive strength exceeding 20 kPa on wet tissue surfaces, swelling ratio less than 50%, and high mechanical strength with good stability.
NEKTAR THERAPEUTICSInjectable drug delivery systems, controlled release formulations for therapeutic proteins and small molecules, and biodegradable implantable matrices for regenerative medicine.Degradable PEG Hydrogel PlatformControlled degradation half-life from 7-180 days through hydrolytic breakdown of ester linkages, yielding non-toxic PEG fragments cleared renally, enabling precise drug release kinetics without substantial non-PEG toxic components.
Rutgers The State University of New JerseyWound dressings, ophthalmic surface treatments, vaginal mucosa applications, and removable surgical adjuvants requiring temporary tissue coverage with controlled adhesion.Spray-On Reversible Crosslinked PEG HydrogelIn situ gelation via thioether or disulfide bond formation with rapid crosslinking upon mixing, reversible crosslinks enabling easy removal by dissolution using reducing solutions, and RGD peptide derivatization for enhanced tissue retention.
Boston Scientific Scimed Inc.Surgical sealants for dura mater and vascular sealing, hemostatic agents, anti-adhesion barriers, hernia repair, and tissue engineering scaffolds for soft tissue reconstruction.Succinimidyl Glutarate-Functionalized Star PEG HydrogelGelation time of 10-60 seconds depending on concentration and pH, compressive moduli ranging 1-50 kPa, tunable degradation profiles, and amine-NHS coupling chemistry enabling biocompatible crosslinking without toxic byproducts.
Kyungpook National University Industry-Academic Cooperation FoundationCell carriers, drug delivery vehicles, anti-adhesion agents, wound dressings, dental and orthopedic fillers, and skin fillers for tissue regeneration and therapeutic applications.Electron Beam-Crosslinked PEG-Hyaluronic Acid HydrogelChemical-free crosslinking via electron beam irradiation at 10-50 kGy without toxic additives, compressive modulus 10-50 kPa, degradation time 3-40 days, sterile production, and excellent biocompatibility.
Reference
  • Polyethylene glycol derivative, preparation method thereof, and polyethylene glycol hydrogel capable of producing a rapid crosslinking reaction
    PatentActiveUS12297320B2
    View detail
  • Degradable poly(ethylene glycol) hydrogels with controlled half-life and precursors therefor
    PatentInactiveUS7964217B2
    View detail
  • Dressing compositions and methods
    PatentWO2008133918A1
    View detail
If you want to get more related content, you can try Eureka.

Discover Patsnap Eureka Materials: AI Agents Built for Materials Research & Innovation

From alloy design and polymer analysis to structure search and synthesis pathways, Patsnap Eureka Materials empowers you to explore, model, and validate material technologies faster than ever—powered by real-time data, expert-level insights, and patent-backed intelligence.

Discover Patsnap Eureka today and turn complex materials research into clear, data-driven innovation!

Group 1912057372 (1).pngFrame 1912060467.png